National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 366154

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 366154
VAERS Form:
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 9/14/2017

VAERS ID: 366154 Before After
VAERS Form:(blank) 1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 2/14/2018

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 6/14/2018

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 8/14/2018

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 9/14/2018

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 10/14/2018

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 12/24/2020

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 12/30/2020

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 5/7/2021

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.


Changed on 5/21/2021

VAERS ID: 366154 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-10-23
Onset:2009-10-23
Submitted:2009-11-09
Entered:2009-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Feeling cold, Injection site pain, Postmenopausal haemorrhage

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Menopausal
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601901A

Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=366154&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166